A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
Denys-Drash syndrome (DDS) is characterized by nephropathy, genital abnormalities, and predisposition to Wilms tumor. DDS is associated with constitutional WT1 mutations, the majority being missense mutations in the zinc-finger region. A dominant-negative mode of action of the mutant DDS proteins is thought to explain the more severe genitourinary phenotype seen in DDS compared with children with complete deletion of one WT1 allele. We present a phenotypically female child who presented with bilateral Wilms tumor at 8 months of age. She was found to have an XY karyotype and diagnosed with DDS. In the constitutional DNA of this child we found a previously unreported mutation in exon 1 of WT1. This de novo mutation, delT in codon 40, is predicted to produce a termination signal in codon 90 (F40fsX90). This frameshift mutation results in a severely truncated protein, which would remove both the zinc-finger DNA-binding domain and the majority of the N-terminal regulatory domain, including regions previously shown in vitro to be necessary for inhibition of WT1 transcriptional activity. Our results provide important physiological evidence that the first 40 amino acids of WT1 are capable of functionally important interactions, presumably through their ability to self-associate with full-length WT1.
Little
Suzanne
S
Section of Paediatric Oncology, Institute of Cancer Research, Sutton, Surrey, UK.
Hanks
Sandra
S
King-Underwood
Linda
L
Picton
Sue
S
Cullinane
Catherine
C
Rapley
Elizabeth
E
Rahman
Nazneen
N
Pritchard-Jones
Kathy
K
D030321:Denys-Drash Syndrome / Q000235:genetics*; D005260:Female; D016162:Genes, Wilms Tumor; D006801:Humans; D007223:Infant; D009154:Mutation